ALB-127158A
| CAS No. | 1173154-32-9 | Cat. No. | BCP32660 |
| Name | ALB-127158A | ||
| Synonyms | ALB 127158A; ALB127158A; ALB-127158(a); ALB127158(a); ALB 127158(a); ALB-127158; ALB 127158; ALB127158; | ||
| Formula | C23H21FN4O2 | M. Wt | 404.43 |
| Description | ALB-127158A is a MCH1 antagonist for the treatment of obesity. Preclinical studies demonstrated that the compound produced significant weight loss in rodents. ALB-127158(a) may be a potential treatment for IBD. This example demonstrates how using data from the preclinical studies is possible to build decision points into an early clinical development plan that will allow early assessment of potential efficacy and allow timely go/no go decisions. | ||
| Pathways | Hormone Pathay GPCR/G Protein | ||
| Targets | GPR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.